Detalhe da pesquisa
1.
Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.
Int J Cancer
; 146(11): 3053-3064, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31970771
2.
Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome.
Int J Cancer
; 145(11): 2963-2973, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30963573
3.
Integrated Histogenetic Analysis Reveals BAP1-Mutated Epithelioid Mesothelioma in a Patient With Cancer of Unknown Primary.
J Natl Compr Canc Netw
; 16(6): 677-682, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891518